Latest news with #TorrentPharmaceuticals


India.com
2 days ago
- Entertainment
- India.com
Heeramandi Actress Sharmin Segal, Husband Aman Mehta Blessed With Baby Boy: Report
New Delhi: Heeramandi fame actress and niece of Sanjay Leela Bhansali, Sharmin Segal, has welcomed a baby boy with her husband, Aman Mehta. As per journalist Vickey Lalwani's Instagram post, Sharmin Segal and Aman Mehta welcomed a baby boy on Wednesday. Sharmin lives with her husband Aman Mehta, who is the Executive Director at Torrent Pharmaceuticals in Ahmedabad. They tied the knot in an intimate ceremony in Italy in November 2023. The report states that Sanjay, along with her parents Bela and Deepak, are thrilled. 'That Sharmin Segal, Sanjay Leela Bhansali's niece and Deepak-Bela Segal's daughter, was expecting her first baby was brought to you here FIRST. The news now is that Sharmin has delivered a baby boy. Sharmin became a mother on May 28. Sharmin made her Bollywood splash, playing Alamzeb, in Sanjay Leela Bhansali's acclaimed web show Heeramandi, which hit online on May 1 last year and airs on Netflix. Sharmin married Aman Mehta, the Executive Director of Torrent Pharmaceuticals, in 2023. She is settled in Ahmedabad after marriage but has been in Mumbai for the past few months. Goes without saying that Sanjay, Bela, and Deepak are thrilled. Ditto for Sharmin and Aman.' — the post read. The actress is known for her work in Malal and Heeramandi as Alamzeb. She received mixed responses for her performance in the Netflix web series. Since then, she has taken a step back from the industry.


Pink Villa
3 days ago
- Entertainment
- Pink Villa
Heeramandi fame Sharmin Segal and husband Aman Mehta welcome their first child, find out gender
Heeramandi star Sharmin Segal has reportedly welcomed a baby boy. The actress, who is also the niece of filmmaker Sanjay Leela Bhansali, is said to have given birth to her first child with husband Aman Mehta on May 28, 2025, according to journalist Vickey Lalwani. As of now, the couple has not made any official announcement on social media regarding the birth Sharmin Segal is married to Aman Mehta, who holds the position of Executive Director at Torrent Pharmaceuticals, a subsidiary of the Torrent Group. The couple exchanged vows in an intimate wedding ceremony in Italy in November 2023. Although Sharmin initially moved to Ahmedabad following her marriage, she has been staying in Mumbai in recent months. The Bhansali family, including Sharmin and Aman, Sanjay Leela Bhansali, and her parents Deepak and Bela Bhansali Segal, is reportedly elated by the arrival of the baby boy On the work front, Sharmin Segal last appeared in Sanjay Leela Bhansali's Netflix series Heeramandi, which debuted in May last year. She portrayed the character of Alamzeb in the historical drama. Segal began her career in the film industry with her acting debut in the 2019 movie Malaal, which was produced by Sanjay Leela Bhansali. Before entering the spotlight as an actress, she gained experience working behind the camera as an assistant director on films such as Bajirao Mastani. Her portrayal of Alamzeb in the Netflix period drama Heeramandi stands out as one of her most prominent performances so far. She was also seen in the horror-comedy Atithi Bhooto Bhava, where she shared screen space with Jackie Shroff and Pratik Gandhi. The arrival of Sharmin Segal and Aman Mehta's baby boy marks a heartwarming new beginning for the couple, bringing immense joy to the Bhansali family. As Sharmin continues to grow in her cinematic journey, the unwavering support from her loved ones and admirers remains a pillar of strength. Welcoming their son is a treasured milestone, embraced with warmth amid the ever-evolving world of showbiz. Pinkvilla extends heartfelt congratulations to Sharmin and Aman, wishing them endless happiness and blessings in their new role as parents!


Time of India
3 days ago
- Entertainment
- Time of India
'Heeramandi' fame and Sanjay Leela Bhansali's niece Sharmin Segal welcomes a baby boy with husband Aman Mehta
Sharmin Segal, known for her role in Heeramandi, and husband Aman Mehta have welcomed a baby boy, bringing joy to the Bhansali-Mehta family. The couple married in Italy in November 2023. Sharmin, Sanjay Leela Bhansali's niece, faced mixed reactions to her Heeramandi performance but learned to embrace both praise and criticism. After making headlines for her role as Alamzeb in Heeramandi, actress Sharmin Segal now has a special new chapter to celebrate. The actress, who is also Sanjay Leela Bhansali 's niece, has reportedly welcomed a baby boy with husband Aman Mehta — marking a joyous milestone for the Bhansali-Mehta family, journalist Vickey Lalwani shared on his Instagram. Family Celebrations Sharmin is married to Aman Mehta, Executive Director at Torrent Pharmaceuticals, part of the Torrent Group. The couple tied the knot in a private ceremony in Italy in November 2023. After marriage, Sharmin moved to Ahmedabad but has been in Mumbai in recent months. The entire Bhansali family — including Sharmin, Aman, Sanjay Leela Bhansali, and her parents Deepak and Bela Bhansali Segal — is reportedly thrilled about the arrival of the baby boy. Facing Criticism and Finding Growth In an earlier interview with News18 Showsha, Sharmin Segal opened up about the mixed reactions to her performance as Alamzeb in Heeramandi. She acknowledged receiving both praise and criticism, but noted that the negative feedback seemed to get more attention. Sharmin pointed out that people often overlook the appreciation amid the criticism. Initially, she distanced herself from discussions and even disabled comments on her social media posts. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Doutora: bolsas nos olhos sem cirurgia (em qualquer idade) Revista Saúde & Beleza Saiba Mais Undo However, she eventually chose to engage with the feedback. Sharmin admitted that by avoiding reviews, she was also missing out on the positive responses. This change in perspective helped her accept both compliments and critiques as part of her learning journey. On the work front, Sharmin Segal was last seen in Sanjay Leela Bhansali's Netflix series Heeramandi, which premiered in May last year. She played the role of Alamzeb in the period drama. Sharmin began her career as an assistant director to her uncle Sanjay Leela Bhansali, before making her acting debut in his 2019 production Malaal. Check out our list of the latest Hindi , English , Tamil , Telugu , Malayalam , and Kannada movies . Don't miss our picks for the best Hindi movies , best Tamil movies, and best Telugu films .


News18
3 days ago
- Entertainment
- News18
Heeramandi Fame Sharmin Segal Welcomes Baby Boy With Husband Aman Mehta
Last Updated: It's a boy! Sanjay Leela Bhansali's niece Sharmin Segal has welcomed her first child with husband Aman Mehta. Congratulations are in order as Heeramandi actress Sharmin Segal has welcomed her first child – a baby boy – with her husband, Aman Mehta. Sharmin, niece of filmmaker Sanjay Leela Bhansali, delivered her baby boy on May 28, reports journalist Vickey Lalwani. However, it should be noted that neither Sharmin nor her husband Aman has announced the news yet on social media. Sharmin Segal is married to Aman Mehta – the Executive Director for Torrent Pharmaceuticals, a division of the Torrent Group. The two tied the knot in a private ceremony in November 2023 in Sharmin settled in Ahmedabad post marriage, she has been in Mumbai in recent months. The entire Bhansali family – including the new parents, Sharmin and Aman; Sanjay Leela Bhansali; and Sharmin's parents, Deepak and Bela Bhansali Segal – is overjoyed at the arrival of the newborn! Meanwhile, on the professional front, Sharmin Segal was seen in Sanjay Leela Bhansali's Netflix series 'Heeramandi' which premiered in May last year. She played the role of Alamzeb in the period drama series. Sharmin forayed into the film industry with her acting debut in the 2019 film 'Malaal', a Sanjay Leela Bhansali production co-starring Meezan Jafri. Having closely worked with SLB as an assistant director on projects like 'Bajirao Mastani', Sharmin expanded her roles into acting post 'Malaal'. She also starred in the horror comedy film 'Atithi Bhooto Bhava', co-starring Jackie Shroff and Pratik Gandhi. Sharmin Segal faced massive criticism after the release of 'Heeramandi: The Diamond Bazaar' in May 2024. Her performance in the show left many disappointed. Sharmin also reacted to the trolling later. 'I've been working on my mental health for a very long time in my life now. It is just not throughout my acting life. It is something when you start understanding yourself better, it becomes a lot easier to realise that you live in a very vast world where people with a lot of opinions," she told Pinkvilla. First Published:


Business Standard
21-05-2025
- Business
- Business Standard
Torrent Pharma gains as Q4 PAT rises 11% YoY to Rs 498 cr; recommends final dividend of Rs 6/sh
Torrent Pharmaceuticals added 1.53% to Rs 3,292.95 after the company's consolidated net profit increased 10.91% to Rs 498 crore in Q4 FY25 as against Rs 449 crore posted in Q4 FY24. Total revenue from operations grew 7.79% year on year (YoY) to Rs 2,959 crore in the quarter ended 31 March 2025. Profit before tax stood at Rs 665 crore in March 2025 quarter, up 5.38% from Rs 631 crore posted in same quarter last year. Operating EBITDA stood at Rs 964 crore in Q4 FY25, registering a growth of 9.17% as against Rs 883 crore reported in Q4 FY24. The operating EBITDA margin improved to 32.6% in Q4 FY25, up from 32.2% in the previous year. Torrent Pharmaceuticals reported India revenues of Rs 1,545 crore in Q4 FY25, marking a 12% year-on-year growth, driven by strong performance in focus therapies. According to AIOCD secondary market data, the Indian Pharmaceutical Market (IPM) grew 8% during the quarter. Torrent's chronic segment outpaced the market, posting a 14% growth compared to IPMs 9% rise in the same category. On a MAT (Moving Annual Total) basis, Torrent continued to outperform the industry across key therapy areas, supported by robust new product launches. The company currently has 21 brands ranked among the Top 500 in the IPM, with 14 brands clocking over Rs 100 crore in annual sales. Brazil revenues for Torrent Pharma stood at Rs 351 crore, marking a decline of 6%, primarily impacted by the steep depreciation of the Brazilian Real (BRL). However, constant currency revenues were $ 234 million, reflecting a 5% increase. The company also faced a challenge due to a lower-than-expected annual price increase on April 1st, which led wholesalers to reduce their inventory more than usual. According to IQVIA data, Torrent grew at 13%, outperforming the market's growth of 7%. Additionally, Torrent currently has sixty-three products under review by ANVISA. The company reported revenues of Rs 286 crore from its Germany operations in Q4 FY25, registering a 2% year-on-year growth. In constant currency terms, revenues stood at 31 million, up 1% YoY. The company attributed the modest growth to continued success in securing new tender wins, supported by ongoing cost improvement initiatives. Torrent Pharmaceuticals reported a 15% year-on-year rise in US business revenue at Rs 302 crore for Q4 FY25. In constant currency terms, revenue stood at $35 million, marking a 10% increase compared to the same period last year. On a full year basis, the companys net profit rallied 15.39% to Rs 1,911 crore on 7.34% rise in total revenue from operations to Rs 11,516 crore in FY25 over FY24. Torrent Pharmaceuticals reported strong performance in its India business for FY25, with revenues rising 13% year-on-year to Rs 6,393 crore. In Brazil, revenue declined 2% to Rs 1,100 crore; however, in constant currency terms, it grew 9% to R$734 million. The Germany business posted a 6% increase in revenue to Rs 1,139 crore, with constant currency growth of 5% at 126 million. Meanwhile, the US business recorded a 2% rise in revenue to Rs 1,100 crore. In constant currency, US revenue stood at $130 million, with flat growth of 1% after adjusting for one-off income in FY24. Meanwhile, the board recommended a final dividend of Rs 6 per equity share of Rs 5 each. Earlier an interim dividend of Rs 26 per equity share was paid during the last quarter, it added. Further, the board has approved the appointment of Aman Mehta as Managing Director, effective 1st August 2025. Lastly, the company said its board has recommended that members seek enabling approval to raise up to Rs 5,000 crore through the issuance of equity shares, including via convertible bonds/debentures, through qualified institutional placement (QIP) or any other modes at the upcoming annual general meeting. Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.